Updated: May 19, 2026

Bradley J Phd Bolzon

CRSPCRISPR Therapeutics AGSEC CIK: 0001354345
Estimated Net Worth
$27 Million
Last Updated: May 19, 2026 03:20 AM EST

Transaction Summary

Total Transactions98
Buy-Sell Ratio0.21
Buy Transactions10
Sell Transactions48

Transaction Volume

Total Volume-$108.28M
Net Volume$168.55M
Buy Volume$30.13M
Sell Volume-$138.41M

Trade Analysis

AVG Trade Size-$949.89K
Largest Trade$15.50M
Most Active MonthNov
Most Active Year2020

Trading Sentiment

OverallBullish
Recent TradeNeutral
Last 90 Days0 Trades
ConvictionNone

Net Worth & Trading Activity Over Time

Loading...

Monthly Trading Pattern

Loading...

Past Insider Trading and Trends

Bradley J Phd Bolzon has an estimated net worth of $27 Million. This is based on reported shares across multiple companies, which include Inogen Inc, SECOND SIGHT MEDICAL PRODUCTS INC, HELICOS BIOSCIENCES CORP, Alexza Pharmaceuticals Inc., Flexion Therapeutics Inc, Monte Rosa Therapeutics, Inc., CRISPR Therapeutics AG, Black Diamond Therapeutics, Inc., NOVACEA INC, and PHASERX, INC..



2020 was Bradley J Phd Bolzon's most active year for acquiring shares with 20 total transactions. Bradley J Phd Bolzon's most active month to acquire stocks was the month of May. 2021 was Bradley J Phd Bolzon's most active year for disposing of shares, totalling 27 transactions. Bradley J Phd Bolzon's most active month to dispose stocks was the month of May. 2017 saw Bradley J Phd Bolzon paying a total of $0.00 for 55,447 shares, this is the most they've acquired in one year. In 2020 Bradley J Phd Bolzon cashed out on 340,648 shares for a total of $5,869,624.72, their largest year based on trade value.

Holdings & Transactions

CRSPcrispr therapeutics ag
Updated: Jun 10, 2022VIEW QUOTE
Form TypeSEC Filing
12.00K12.00KJun 09View
-0.0610.00K$126.43-$1.26M498.56KScheduledJul 19View
-0.671.04M$149.49-$7.11M510.25KScheduledJun 28 - 29View
-0.1630.38K$152.48-$4.63M158.83KScheduledJun 28View
-0.3310.00K$126.61-$1.27M1.58MScheduledJun 11View
10.00K10.00KJun 10View
-0.5030.37K$132.37-$4.02M1.59MScheduledMar 22View
-0.24264.88K1.72MScheduledMar 01View
-0.361.16M$149.11-$25.50M2.04MFeb 19View
-0.0415.00K$148.95-$2.23M3.04MScheduledDec 16View
-0.8133.00K$143.35-$4.73M3.06MScheduledDec 10View
-0.1033.00K$143.35-$4.73M3.06MScheduledDec 10View
-0.33171.00K$154.53-$26.42M3.09MDec 07View
-0.22394.36K3.26MScheduledOct 29View
-0.15315.49K3.65MScheduledSep 22View
-0.013.04K$86.87-$263.64K3.97MScheduledSep 18View
-0.028.96K$86.98-$779.78K3.97MScheduledSep 16View
-0.001.16K$84.89-$98.05K3.98MScheduledSep 14View
-0.06180.59K$85.36-$1.95M3.98MScheduledSep 09 - 10View
-0.5060.00K$58.87-$4.04M4.22MSep 01View
-0.0320.00K$82.39-$1.65M4.16MScheduledJul 06View
-0.0320.00K$73.93-$1.48M4.18MScheduledJun 22 - 23View
15.00K15.00KJun 11View
-0.0742.00K$67.41-$2.83M4.21MScheduledNov 19View
-0.6021.00K$51.89-$1.09M4.25MScheduledOct 30View
15.00K15.00KJun 11View
30.00K30.00KJun 15View
-0.0644.00K$57.99-$2.55M674.76KMay 15View
-0.04128.95K$50.76-$6.50M2.76MScheduledMay 07 - 08View
-0.0230.57K$50.28-$1.54M1.52MScheduledApr 30View
-0.07222.26K$50.08-$11.14M3.03MScheduledApr 26 - 27View
-0.0122.84K$50.90-$1.16M1.73MScheduledApr 24View
-0.13585.73K$50.83-$5.17M4.05MScheduledApr 20 - 23View
-0.4826.02K$20.30-$528.24K27.72KScheduledDec 22View
-0.031.71K$20.21-$34.50K53.74KScheduledNov 24 - 27View
-0.332.25M4.66MSep 05View
30.00K30.00KMay 31View
0.03191.00K$14.007.65MOct 18 - 24View
From 3/A923.66KView
30.00K30.00KOct 18View
581.66KView
GLUEmonte rosa therapeutics, inc.
Updated: Jun 30, 2021VIEW QUOTE
Form TypeSEC Filing
-0.7021.24M$19.008.90MJun 28View
1.776.32M$2.32$15.15M9.90MFeb 24 - 23View
283.25KView
BDTXblack diamond therapeutics, inc.
Updated: Jun 22, 2021VIEW QUOTE
Form TypeSEC Filing
15.00K15.00KJun 18View
-0.0220.77K6.45MScheduledDec 14View
-0.08433.30K$33.15-$344.51K6.47MScheduledNov 27 - 30View
-0.10757.98K6.91MNov 23View
-0.02130.02K$33.01-$4.29M7.66MScheduledNov 19View
-0.004.73K$33.07-$156.35K13.71MScheduledNov 17 - 18View
-0.004.70K$33.39-$158.59K13.72MScheduledNov 13 - 16View
-0.07960.14K$34.15-$532.64K12.76MScheduledNov 11 - 12View
-0.0039.58K$34.28-$1.35M15.41MScheduledNov 10 - 11View
-0.009.40K$33.10-$310.95K15.48MScheduledNov 06 - 09View
-0.0011.35K$33.15-$376.13K15.50MScheduledNov 04 - 05View
-0.008.90K$33.17-$296.29K15.52MScheduledOct 26 - 27View
-0.0015.75K$33.34-$526.53K22.25MScheduledOct 15 - 19View
-0.0017.24K$33.24-$574.02K15.57MScheduledOct 13 - 14View
-0.0022.63K$33.42-$757.92K22.34MScheduledOct 08 - 12View
-0.02334.06K$33.41-$1.54M16.75MScheduledOct 06 - 07View
-0.07725.44K9.22MScheduledSep 17View
-0.05298.28K9.95MAug 18View
-0.04298.28K10.24MScheduledAug 12View
-0.0013.79K$33.06-$455.99K18.47MScheduledAug 10 - 11View
-0.08327.73K10.56MScheduledJul 27View
-0.3518.57M$19.00$15.50M33.98MFeb 03View
331.59KView
flexion therapeutics inc
Updated: Jun 10, 2016
Form TypeSEC Filing
0.25714.28K$14.00$10.00M3.92MJun 08View
$17.61$39.62K9.00KSep 10View
9.00K9.00KMar 03View
-0.8619.61M$13.003.21MFeb 18View
105.78KView
phaserx, inc.
Updated: May 24, 2016
Form TypeSEC Filing
0.21341.96K$2.51$3.00M1.94MMay 23View
From 3/A1.60MView
1.54MView
INGNinogen inc
Updated: May 11, 2015VIEW QUOTE
Form TypeSEC Filing
-0.11384.69K$24.30-$179.53K3.03MNov 05 - 07View
-0.35735.77K1.39MJan 06 - 07View
-1.007.95K$30.98-$246.16K2.13MJan 05View
-0.18478.05K2.15MDec 18View
-1.009.79K$29.74-$291.01K2.14MDec 23View
-0.18478.05K2.15MDec 18View
-0.4128.23K$24.80-$699.25K2.62MNov 17 - 19View
-0.22753.69K$25.13-$237.09K2.65MNov 12 - 14View
-1.008.64K$24.53-$211.69K3.41MNov 10View
0.044.44K$24.30-$179.53K3.41MNov 05 - 07View
3.41MView
3.41MView
-0.7751.70K3.41MOct 07View
VANIsecond sight medical products inc
Updated: Dec 02, 2014VIEW QUOTE
Form TypeSEC Filing
From 3/A4.49MView
4.49MView
helicos biosciences corp
Updated: Sep 21, 2009
Form TypeSEC Filing
0.03403.75K$1.33$638.33K15.90MSep 18View
6.4613.79M15.93MDec 23View
-0.776.97M$9.00$1.00M2.14MMay 30View
View
alexza pharmaceuticals inc.
Updated: Mar 14, 2006
Form TypeSEC Filing
-0.808.95M2.18MMar 13View
View
novacea inc
Updated: May 15, 2006
Form TypeSEC Filing
0.13230.77K2.07MMay 15View
View